Phase I/II Study of Intraperitoneal Floxuridine and Platinums (Cisplatin and/or Carboplatin)
- 1 August 1997
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 66 (2) , 290-294
- https://doi.org/10.1006/gyno.1997.4778
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Intraperitoneal Mitoxantrone or Floxuridine: Effects on Time-to-Failure and Survival in Patients with Minimal Residual Ovarian Cancer after Second-Look Laparotomy—A Randomized Phase II Study by the Southwest Oncology GroupGynecologic Oncology, 1996
- Intraperitoneal 5-fluoro-2?-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity studyCancer Chemotherapy and Pharmacology, 1995
- Ovarian cancer: Diagnostic second laparotomy and salvage intra-peritoneal chemotherapy fail againEuropean Journal Of Cancer, 1995
- PaclitaxelDrugs, 1994
- Intraperitoneal 5-fluoro-2′-deoxyuridine with escalating doses of leucovorin: Pharmacology and clinical toleranceInvestigational New Drugs, 1994
- Intraperitoneal Carboplatin and Etoposide for Persistent Epithelial Ovarian Cancer: Analysis of Results by Prior Sensitivity to Platinum-Based RegimensGynecologic Oncology, 1993
- Intraperitoneal salvage chemotherapy in ovarian cancer: Who is left to treat?Gynecologic Oncology, 1992
- Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2′-deoxyuridineCancer Chemotherapy and Pharmacology, 1991
- Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapy.Journal of Clinical Oncology, 1990
- Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy.Journal of Clinical Oncology, 1987